For citations:
Konoplya N.E., Kalenik O.A., Severin I.N., Savritskaya A.A., Bobrova N.M., Doroshenko T.M., Portyanko A.S. Use of locally produced anti-CD19 CAR-T cells in the treatment of relapsed/refractory B-cell lymphomas in adults. Oncohematology. 2023;18(3):26-34. (In Russ.) https://doi.org/10.17650/1818-8346-2023-18-3-26-34
Email this article 